CDKN2B and laryngotracheoesophageal cleft: For the purpose of learning more about the impacts of CDKN2B-AS1 on LC and its clinical value, we analyzed CDKN2B-AS1 expression in LC cases, its changes during interventional therapy, and the mechanism of action, with the goal of offering a novel reference for the future diagnosis and therapy of LC and laying a reliable foundation for the follow-up research.